$18.93
0.13% today
NYSE, Sep 16, 08:48 pm CET
ISIN
US58470H1014
Symbol
MED

Medifast Inc Stock price

$18.90
-0.19 1.00% 1M
-16.85 47.13% 6M
-48.32 71.88% YTD
-62.18 76.69% 1Y
-214.35 91.90% 3Y
-87.15 82.18% 5Y
-14.54 43.48% 10Y
NYSE, Closing price Fri, Sep 13 2024
+0.13 0.69%
ISIN
US58470H1014
Symbol
MED

Key metrics

Market capitalization $206.72m
Enterprise Value $62.31m
P/E (TTM) P/E ratio 7.05
EV/FCF (TTM) EV/FCF 1.15
EV/Sales (TTM) EV/Sales 0.08
P/S ratio (TTM) P/S ratio 0.27
P/B ratio (TTM) P/B ratio 1.01
Dividend yield 34.71%
Last dividend (FY22) $6.56
Revenue growth (TTM) Revenue growth -43.90%
Revenue (TTM) Revenue $770.18m
EBIT (operating result TTM) EBIT $34.25m
Free Cash Flow (TTM) Free Cash Flow $54.40m
Cash position $163.51m
EPS (TTM) EPS $2.68
P/E forward negative
P/S forward 0.34
EV/Sales forward 0.10
Short interest 28.80%
Show more

Is Medifast Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.

Medifast Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Medifast Inc forecast:

1x Hold
50%
1x Sell
50%

Analyst Opinions

2 Analysts have issued a Medifast Inc forecast:

Hold
50%
Sell
50%

Financial data from Medifast Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
770 770
44% 44%
100%
- Direct Costs 201 201
48% 48%
26%
569 569
42% 42%
74%
- Selling and Administrative Expenses 514 514
33% 33%
67%
- Research and Development Expense 4.60 4.60
5% 5%
1%
51 51
76% 76%
7%
- Depreciation and Amortization 16 16
7% 7%
2%
EBIT (Operating Income) EBIT 34 34
82% 82%
4%
Net Profit 29 29
78% 78%
4%

In millions USD.

Don't miss a Thing! We will send you all news about Medifast Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Medifast Inc Stock News

Positive
Seeking Alpha
13 days ago
Medifast's collaboration with LifeMD and acquisition of LifeMD shares are expected to boost business growth and free cash flow. The company's holistic approach combining weight loss formulas, coaches, and GLP-1 medication is a significant competitive advantage. Recent investments in marketing and supply chain optimization initiatives, including the Maryland Distribution Center closure, are like...
Neutral
Seeking Alpha
about one month ago
Medifast, Inc. (NYSE:MED ) Q2 2024 Earnings Conference Call August 5, 2024 4:30 PM ET Company Participants Steven Zenker - Vice President, Investor Relations Dan Chard - Chairman and Chief Executive Officer Jim Maloney - Chief Financial Officer Conference Call Participants James Salera - Stephens Linda Bolton-Weiser - D.A. Davidson David Larsen - BTIG Operator And welcome to the Medifast Second...
Neutral
Business Wire
about one month ago
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2024. Second Quarter 2024 Revenue of $168.6 million, with revenue per active earning Coach of $4,972 Independent active earning OPTAVIA Coaches of 33,900 Net loss of $8.2 million (n...
More Medifast Inc News

Company Profile

Medifast, Inc. is a health and wellness company, which engages in the manufacture and distribution of healthy living products and programs. Its platform includes OPTAVIA, which offers its costumers lifelong transformation, one healthy habit at a time. The company was founded by William Vitale in 1980 and is headquartered in Baltimore, MD

Head office United States
CEO Daniel Chard
Employees 634
Founded 1981
Website www.medifastinc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today